Goldman Sachs’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.6M | Buy |
|
|||||
|
2025
Q1 | $14.9M | Buy |
|
|||||
|
2024
Q4 | $16.1M | Sell |
|
|||||
|
2024
Q3 | $18.1M | Buy |
|
|||||
|
2024
Q2 | $14.2M | Buy |
|
|||||
|
2024
Q1 | $12.9M | Sell |
|
|||||
|
2023
Q4 | $17.3M | Buy |
|
|||||
|
2023
Q3 | $8.72M | Sell |
|
|||||
|
2023
Q2 | $10.6M | Sell |
|
|||||
|
2023
Q1 | $10.2M | Buy |
|
|||||
|
2022
Q4 | $11.2M | Sell |
|
|||||
|
2022
Q3 | $16.8M | Buy |
|
|||||
|
2022
Q2 | $9.01M | Sell |
|
|||||
|
2022
Q1 | $22.1M | Buy |
|
|||||
|
2021
Q4 | $5.35M | Buy |
|
|||||
|
2021
Q3 | $1.47M | Sell |
|
|||||
|
2021
Q2 | $2.83M | Buy |
|
|||||
|
2021
Q1 | $2.42M | Sell |
|
|||||
|
2020
Q4 | $2.12M | Buy |
|
|||||
|
2020
Q3 | $686K | Buy |
|
|||||
|
2020
Q2 | $367K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $170K | Buy |
|
|||||
|
2019
Q3 | $95K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $124K | Sell |
|
|||||
|
2018
Q4 | $80K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $202K | Sell |
|
|||||
|
2014
Q4 | $411K | Buy |
|